Quanterix expands laboratory-developed-test menu with launch of neurofilament light chain test
Quanterix on Monday announced the validation of a laboratory developed test (LDT) to quantitatively measure neurofilament light chain (NfL) in serum as an aid in the evaluation of individuals for possible neurodegenerative conditions or other causes of neuronal or central nervous system damage. Read More
Grail launches methylation-based liquid biopsy solution for cancer research in a post-diagnosis setting
Grail on Monday announced the availability of a research-use-only offering for biopharmaceutical companies. The firm is leveraging a targeted methylation platform to analyze cell-free DNA (cfDNA) isolated from peripheral blood for cancer signal interrogation. Read More
Mayo Clinic Laboratories, Helix collaborate to provide suite of laboratory services to biopharma customers
Mayo Clinic Laboratories and Helix on Tuesday announced a strategic collaboration that will provide biopharma customers access to a comprehensive joint laboratory offering for research and development initiatives across the drug development lifecycle. Read More
Berkeley Lights launches optofluidic system
Berkeley Lights, Inc., a life sciences tools company, announced the launch of the Beacon Select, its two-chip, single-cell optofluidic system for cell line development (CLD). Read More
Newly-discovered organelle key to sense of smell
Sweden’s Umeå Universit said this week that its researchers have discovered a previously unknown component inside nerve cells—an organelle that enables the perception of smell. The discovery, published recently in Nature Communications, may have implications for research on olfactory impairment -- a common COVID-19 symptom. Read More
Blood test helps diagnose inaccessible brain tumors
A prospective, blinded study by London’s Imperial College researchers showed the TriNetra-Glio liquid biopsy test, which requires 15 mL of blood, can detect malignant brain tumors. Read More
Protillion Biosciences raises $18M in financing to support therapeutic biomarker discovery
Protillion Biosciences, a privately held biotech company launched in 2019 to identify and optimize new protein therapeutics, on Monday announced the completion of an $18 million Series A financing from Arch Venture Partners and Illumina Ventures. Read More
Immune surprise: alarm protein drives inflammation
Trinity College scientists have discovered that a key immune alarm protein, previously believed to calm the immune response, actually does the opposite. The study, published December 16 in the journal Science Immunology, advances the understanding of autoimmune disorders and how inflammation is regulated. Read More
Prenetics acquiring majority stake in ACT Genomics, expanding position in cancer genetics, precision oncology
Hong Kong-based Prenetics Global, a genomics and diagnostic testing firm, on Friday announced that it is acquiring a majority stake in Taiwan-based precision oncology firm ACT Genomics. Read More
Cofactor Genomics kicks off study of multidimensional immune biomarker assay for NSCLC
Cofactor Genomics on Wednesday announced the commencement of a study of its OncoPrism assay in non-small cell lung cancer (NSCLC). Read More
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter